FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/03/008261 [Registered on: 30/03/2017] Trial Registered Prospectively
Last Modified On: 13/04/2018
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective observational study 
Study Design  Single Arm Study 
Public Title of Study   To check how often and how much pain does a patient get,who is on a breathing machine and is put under deep sleep by medicines in the ICU using a pain scale called CPOT (Critical Care Pain Observation Tool ) in Tata hospital ICU. 
Scientific Title of Study   Evaluation of prevalence and intensity of pain in sedated and ventilated adult patients using Critical Care Pain Observation Tool (CPOT) in a mixed medical-surgical ICU in a tertiary cancer care centre  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Project No 1792 V 2.1 20 JAN 2017  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sheila N Myatra 
Designation  Professor 
Affiliation  Tata Memorial Center 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  02224177050  
Fax  02224146937  
Email  sheila150@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sheila N Myatra 
Designation  Professor 
Affiliation  Tata Memorial Center 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  02224177050  
Fax  02224146937  
Email  sheila150@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Jhanvi Surender Bajaj 
Designation  Junior Resident 
Affiliation  Tata Memorial Center 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  09820952051  
Fax  02224146937  
Email  jhanvi.bajaj@yahoo.in  
 
Source of Monetary or Material Support  
NONE 
 
Primary Sponsor  
Name  NA 
Address  NA 
Type of Sponsor  Other [NA] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sheila Nainan Myatra   Tata Memorial Hospital  Room no MB-117 and MB-217, Intensive care units,Main Building Department of Anesthesiology Critical care and Pain TATA MEMORIAL HOSPITAL Dr E Borges Road Parel Mumbai 400012 India Mumbai MAHARASHTRA
Mumbai
MAHARASHTRA 
02224177050

sheila150@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  critically ill patients and sedated and ventilated for more than 12 hours during their ICU stay,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1Patients above 18 years of age
2Patients sedated and ventilated for more than 12 hours during their ICU stay.
3RASS (Richmond Agitation Sedation Scale) score equal to 0 to negative 3 (optimal sedation where response to pain can be noted)
 
 
ExclusionCriteria 
Details  1Pediatric patients
2Patients sedated and ventilated for less than 12 hours during their ICU stay
3Patients in whom an epidural catheter has been inserted and is in use.
4Patients who do not have intact motor function.
5 RASS (Richmond Agitation Sedation Scale) score > 0 and < -3  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Pain assessment using CPOT Score  once in a day till discharge from ICU or maximum 5 days which ever is earlier  
 
Secondary Outcome  
Outcome  TimePoints 
1 Duration of hospital stay
2rate of sedative and or analgesic infusion at the time of pain assessment
3 evaluate whether the use of CPOT to titrate pain medications will result in better pain management 
Once after completion of study enrollment 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/04/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   NONE YET 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

IntroINTRODUCTION :

Pain assessment is considered a fifth vital sign. Pain is a common phenomenon among ICU patients and in the presence of life-threatening illness or injury, investigation and management of pain is often ignored by the health care team. Pain assessment is considered a fifth vital sign. Pain is a common phenomenon among ICU patients and in the presence of life-threatening illness or injury, investigation and management of pain is often ignored by the health care team. Routine pain assessment leads to improved clinical outcomes, and the newly released clinical practice guidelines of the Society of Critical Care Medicine (2012 SCCM guideline) and the Clinical Practice Guidelines for Pain, Agitation and Delirium, 2013 (PAD guidelines ) strongly recommends the implementation of routine pain assessment.

BACKGROUND :

According to the PAD guidelines 2013, the Behavioral Pain Scale (BPS) and the Critical-Care Pain Observation Tool (CPOT) are the most valid and reliable behavioral pain scales for monitoring pain in medical, postoperative, or trauma (except for brain injury) adult ICU patients who are unable to self-report and in whom motor function is intact and behaviors are observable. The CPOT scale has four sections to be assessed : facial expression, body movements, muscle tension, and compliance with the ventilator for intubated patients or vocalization for extubated patients. Items in each section are scored from 0 to 2, with a possible total score ranging from 0 to 8. . A score more than 2 indicates an unacceptable level of pain requiring an intervention such as administration of an analgesic bolus to bring down the pain. If CPOT score goes down by 2 points, it proves that the high score was due to pain which has been controlled by the intervention.  Studies have shown that use of the CPOT scale provides guidance to Intensivists in making decisions for pain management as well as a decrease in the administration of analgesics and sedatives was observed post-implementation of the scale.It also helps in evaluation of the effectiveness of analgesics by checking the score before and after its administration. The APS and the designated ICU Intensivist are responsible for pain management in critically ill patients admitted to the ICU . As per protocol, mechanically ventilated patients are put on a continous infusion of sedatives and analgesics. Sedation is titrated according to sedation scales but there is no scale used for assessment of pain. Titration of the analgesics is on the basis of subjective assessment of the intensivist. This could be leading to administration of excess or insufficient analgesics. Insufficient analgesic administration could lead to overstimulation of the sympathetic nervous system impeding the healing process. Excess analgesics can cause respiratory depression, bradycardia and hypotension.

Objective:

·         PRIMARY : To assess pain status in adult sedated, ventilated patients, managed using the current pain management protocols in the ICU, using the CPOT score

·         SECONDARY: To evaluate whether the use of CPOT to titrate pain medications will result in better pain management.

Patients and Methods

A. Ethics

The study will be initiated after obtaining the approval of The Institutional Ethics Committee Written informed consent will be taken from the legally accepted representatives of all participating patients.

B. Setting

A 23 bed mixed medical-surgical intensive care unit at Tata Memorial hospital

C. Design

Prospective consecutive 12 monthS observational to study approximately 300 subjects.

D. Patients

Inclusion Criteria

1. Patients above 18 years of age

2. Patients sedated and ventilated for more than 12 hours during their ICU stay.

3. RASS (Richmond Agitation Sedation Scale) score [ APPENDIX 2 ] = 0 to -3 (optimal sedation where response to pain can be noted)

 Exclusion Criteria:

1. Pediatric patients

2. Patients sedated and ventilated for less than 12 hours during their ICU stay

3. Patients in whom an epidural catheter has been inserted and is in use.

4. Patients who do not have intact motor function.

5. RASS (Richmond Agitation Sedation Scale) score > 0 and < -3

E. Sample size

A convenience sample size is being used in this study. The study will be done over a 4 month period. It is expected that approximately 70 patients will be admitted per month. Thus, approximately 300 patients will be studied.

F. Study protocol

1. The prospective study will be conducted in the 23 bed mixed medical and surgical intensive care unit at Tata Memorial Hospital. The date, time, hospital admission diagnosis and ICU diagnosis of the enrolled patients will be noted. The rate of sedative  and / or analgesic infusion at the time of pain assessment will be noted.

2. The investigator will confirm with the treating team that the patient has not undergone any surgical intervention / mobilization/ procedure / painful stimulus half an hour before the CPOT score is calculated. The study will not be performed more than once in the same patient on the same day.

Pain will be assessed by the investigator using the CPOT scale, once a day, at a fixed time. Patient is considered to be in pain if the CPOT score is above 2 [14]. If the score is greater than 2 the patient will be given 50 mcg of fentanyl as rescue bolus and the score will be recalculated 10 minutes after giving the bolus.

The first CPOT score of each patient will also be assessed independently by an ICU resident who is not routinely using the CPOT Scale so as to evaluate the agreement of the scores by a person habituated in using the scale versus a person not who uses the scale infrequently.

The CPOT score will also be assessed independently by another person trained in using the scale who is not part of the study. He will calculate the CPOT score for each patient just after the investigator has calculated the score and after 10 minutes he will recalculate the CPOT score. He will be unaware of investigators CPOT scoring and whether the patient has received the rescue fentanyl bolus or not. Score of the independent trained assessor will be compared with that of the trained investigator for agreement between the scores. This is done to reduce the bias by the investigator assessing the CPOT score to improve the accuracy of the study.

Both the investigator and the independent assessor will be trained to using the scale in all sedated, ventilated patient in the ICU 15 days prior to the study.

The maximum number of days a patient can be assessed as part of the study is 5 days.

Interpretation of the CPOT Score by the Investigator and action therafter :

If the score of the patient is less than or equal to 2 out of 8 the inference is that there is likely minimal to no pain present. No further assessment will be done in that patient.

If the score of the patient is found to be greater than 2 out of 8, the inference is that the patient is in pain. The patient will then be given a rescue bolus of 50 mcg IV Fentanyl. The CPOT score will be recalculated 10 mins after giving the rescue bolus.  

- CPOT score decreases by 2 or more points: It means that the patient’s CPOT score was high due to pain which has been relieved by administration of the rescue bolus.

- CPOT score decreases by 1 point: It could be because of high intensity of pain which is not relieved by a single rescue bolus of the analgesic. Thus, another rescue bolus of 50 mcg fentanyl will be given and the score will be recalculated after 10 minutes. Maximum 2 rescue boluses to be given in a patient.

-CPOT score increases or remains the same : It means that the patient’s CPOT score is high due to an underlying condition other than pain. The patient will not be reassessed further.

The ICU registrar will be informed of the initial and final CPOT scores and the number of boluses given, so that he can make the necessary changes in the further pain management of the patient.

Assessment of secondary objective- - By using CPOT we will be able to detect which patients are still in pain despite getting the usual pain management in ICU and we will give them a rescue analgesic. Thus by using CPOT we may be able to give the patient better pain management. If it is found that several patients are requiring rescue analgesic, we may need to consider revising our ICU pain management strategies.

Demographic data will be presented as mean±S.D or Frequency (Percentage). CPOT scores will be assessed as Frequency (Percentage) of scores being < or = 2 versus >2. Change in CPOT scores after giving rescue boluses will be compared using Paired t test or Wilcoxon signed test as per distribution of data. Categorical variables will be analyzed using Chi-square test or Fisher’s exact test. P-value < 0.05 will be considered statistical significant. IBM SPSS (Version24.0) will be used for analysis. Agreement between scores of trained and untrained investigators will be assessed using Kappa statistics. Agreement between scores of trained investigator and trained assessor  will also be assessed using Kappa statistics.

 
Close